WARREN, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that the management team will participate in a fireside chat at the Piper Sandler Virtual 32nd Annual Healthcare Conference to be held December 1-3, 2020. Aquestive will host one-on-one investor meetings on December 2, 2020.
A webcast of the fireside chat will be available on the “Events and Presentation” page of the Investors section of the Company’s website. A replay of webcast will be available for 30 days following the event. For more information, please visit investors.aquestive.com.
About Aquestive Therapeutics
Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. The Company has commercialized one internally-developed proprietary product to date, Sympazan, has a commercial proprietary product pipeline focused on the treatment of diseases of the central nervous system, or CNS, and other unmet needs, and is developing orally administered complex molecules to provide alternatives to invasively administered standard of care therapies. The Company also collaborates with other pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and has proven capabilities for drug development and commercialization.
Investor inquiries:
Stephanie Carrington
stephanie.carrington@westwicke.com
646-277-1282
2026 Outlook: automated Agentic AI workflows will rapidly emerge as business imperatives to meet patient…
2026 Outlook: automated Agentic AI workflows will rapidly emerge as business imperatives to meet patient…
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#CMSAlignedNetwork--Netsmart, an industry-leading provider of healthcare technology solutions and services for community-based…
From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are…
Potential Schedule III Status Could Improve Legal Clarity for Patients Traveling from Colombia to the…
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…